AzTrials
AzTrials

Children/Youth With Special Healthcare NeedsNCT05056493

Caremap: A Digital Personal Health Record for Complex Care Coordination

A study testing Caremap app in people with Children/Youth With Special Healthcare Needs and Adults With Multiple Chronic Conditions, run by Duke University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will implement a new mobile application ('app') called Caremap to improve care coordination for patients with complex health needs. The goal is to pilot test the mobile app with patients/families and clinic doctors to gather input on how well the app works and how to make it better. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Caremap app
Could I receive a placebo?
No, everyone receives an active treatment
How many people
17 participants
Where
1 siteUnited States
Study dates
1 Sep 2022to 29 Mar 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

None listed.

Who cannot join

  • Non-English speaking
  • Living in long-term, congregate settings - e.g., living in institutionalized settings such as long-term care facility, nursing/long-term rehab facilities
  • Lacks requisite technology to access and use mobile app (e.g., device/tablet/smartphone, home internet, active Epic MyChart account)
  • Lack of decision-making capacity (clinician-determined; e.g., patients with advanced dementia)

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Duke University

    Durham, North Carolina, 27705

Other trials in United States

About this study

This study will implement a new mobile application ('app') called Caremap to improve care coordination for patients with complex health needs. The goal is to pilot test the mobile app with patients/families and clinic doctors to gather input on how well the app works and how to make it better. Investigators plan to enroll up to 40 participants from Duke University for this study. The study is sponsored by Duke's Institute for Health Innovation.

Being tested
Caremap app
Keywords
complex care, mobile health, care coordination

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Caremap appOther

    The Caremap app is intended for organizing and tracking patient-reported health insights over time and sharing those trends and patient-centered goals with their providers, not for urgent/emergent clinical communication. Information shared with providers through the app will be used for clinical care at the discretion of their provider. Use of the app to share information and health insights will not replace usual, existing channels for patient-provider communication (e.g., MyChart, phone calls, email, pager, etc.).

Study groups in NCT05056493
Study groupRoleWhat they receive
Clinical ProvidersExperimentalClinical provider site champions will be invited to participate in web-based quantitative surveys and a semi-structured interview
Receives: Other: Caremap app
Parent/CaregiversExperimentalPatient and parent/caregiver subjects from the participating clinic sites will be enrolled. These participants are all adults - parents or caregivers of children and youth with special health care needs (CYSHCN) and adult patients with multiple chronic conditions (MCC) who are already receiving care at Duke Health.
Receives: Other: Caremap app

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Implementation feasibility as measured by feasibility intervention measure (FIM)

    The feasibility intervention measure is a 4 item survey using a 5-level Likert scale (1=completely disagree; 5=completely agree).

    Measured: 6 months

  2. Technical feasibility as measured by proportion of Fast Healthcare Interoperability Resources (FHIR)-enabled data transfer request that were successfully executed

    Technical feasibility will be defined as proportion of requests for transfer of patient-level data between the electronic health record (EHR) and the app that were successfully completed.

    Measured: Weekly, up to 6 months

  3. Changes in perceptions of care integration as measured by Pediatric Integrated care survey (PICS)

    The PICS is a 20-item survey that gathers parents perspectives on the degree of care integration received by their child using a 6-level Likert scale (1=never; 6=always).

    Measured: Baseline, 6 months

  4. Change in parent report of their child's health-related quality of life (HR-QOL), as measured by the PROMIS (7+2) Parent Proxy Global Health Survey

    For participants who are parents of children with complex health needs, the PROMIS (7+2) Pediatric Global Health Survey is a 9-item parent-reported survey that gathers parent perspectives on their child's overall HR-QOL. Four of the 9 survey items use a 5-level Likert scale with 1=poor and 5=excellent; three of the 9 survey items use a 5-level Likert scale with 1=never and 5=always; and three of the 9 survey items use a 5-level Likert scale with 1=never and 5=almost always.

    Measured: Baseline, 3 months, 6 months

  5. Change in patient-reported health-related quality of life (HR-QOL), as measured by the PROMIS Global Health Survey

    For participants who are adult patients with complex health needs, the PROMIS Global Health Survey is a 10-item patient-reported survey that gathers patient perspectives on their own overall HR-QOL. Six of the 9 survey items use a 5-level Likert scale with 1=poor and 5=excellent; one of the 9 survey items uses a 5-level Likert scale with 1=not at all and 5=completely; one of the 9 survey items uses a 5-level Likert scale with 1=never and 5=always; one of the 9 survey items uses a 5-level Likert scale with 1=none and 5=very severe; and one of the 9 survey items uses a 0-10 scale (0=no pain; 10=worst pain imaginable).

    Measured: Baseline, 3 months, 6 months

Secondary outcomes (9)
  1. Changes in adoption as measured by quantitative measurement of app engagement by patient or parent/caregiver

    App engagement will be defined by number of app log-ins by the parent/patient

    Measured: Weekly, up to 6 months

  2. Changes in adoption as measured by quantitative measurement of app engagement by provider

    App engagement will be defined by number of views of the clinician dashboard by the provider

    Measured: Monthly, up to 6 months

  3. Changes in adoption as measured by quantitative measurement of app prescription by provider

    App prescription is the process by which a clinical providers recommends the app to their patient(s) by sending the link for downloading the app, app user overview materials, and study-related materials (including e-informed consent) to the patient directly through the EHR online patient portal. This process is called a "digital prescription" of the app and will be tracked as a marker of app adoption by providers.

    Measured: Monthly, up to 6 months

  4. Adaptations made by families and providers during real-world use as measured by survey

    Adaptation survey is a 5-item item survey based on the published Framework for Reporting Adaptations and Modifications to Evidence-Based Interventions (FRAME) and is designed to gather patient/parent and providers perspectives on how they have adapted the use and implementation of Caremap in real-world settings.

    Measured: Monthly, up to 6 months

  5. Mobile app usability as measured by the System Usability Scale (SUS)

    The System Usability Scale is a 10 item survey that gathers user-reported ratings (from parents/patients and providers) of the usability of the Caremap app

    Measured: 6 months

  6. Change in parent/caregiver self-management, as measured by the Parent-Patient Activation Measure (P-PAM)

    The Parent-Patient Activation Measure (P-PAM) is a 13-item parent-reported survey that uses a 4-level Likert scale (1=disagree strongly; 4=agree strongly).

    Measured: Baseline, 6 months

  7. Change in patient activation and ability to self manage chronic conditions, as measured by the Patient Activation Measure (PAM)

    The PAM is a 13-item survey that uses a 4-level Likert scale (1=disagree strongly; 4=agree strongly).

    Measured: Baseline, 6 months

  8. Changes in caregiver or patient report of global health status as measured by a numeric rating scale of 1 (poor) to 10 (excellent)

    The numeric rating scale is 1 question

    Measured: Weekly for 6 months

  9. Changes in acute and outpatient healthcare utilization, as measured by summary of clinical encounters

    Acute encounters include hospital admissions and emergency department visits; and outpatient encounters include primary and specialty clinic visits

    Measured: Baseline, 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Sep 2021
  2. Study start1 Sep 2022
  3. Primary completion29 Mar 2024
  4. Study completion29 Mar 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
17 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05056493
Sponsor's protocol ID
Pro00108191
Status last verified
Nov 2024
First submitted
20 Sep 2021
Last updated
21 Nov 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Caremap app in people with Children/Youth With Special Healthcare Needs and Adults With Multiple Chronic Conditions, run by Duke University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Implementation feasibility as measured by feasibility intervention measure (FIM) (time frame: 6 months). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Nov 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in